About Leica Biosystems
Leica Biosystems is a company based in Nussloch (Germany) founded in 1989 by Helmut Zarbl. It operates as a B2B. Leica Biosystems has completed 5 acquisitions, including Aperio Technologies, Cell IDx and Kreatech. Leica Biosystems offers products and services including Aperio GT 450 DX, BOND IHC-ISH Instruments, and HistoCore PERMA S. Leica Biosystems operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
- Headquarter Nussloch, Germany
- Founders Helmut Zarbl
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Leica Biosystems Nussloch Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Aperio Technologies
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Leica Biosystems
Leica Biosystems offers a comprehensive portfolio of products and services, including Aperio GT 450 DX, BOND IHC-ISH Instruments, and HistoCore PERMA S. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated scanner for high-capacity digital pathology slide imaging.
Instruments for advanced IHC and ISH staining in cancer diagnostics.
Compact system for slide printing and specimen tracking in labs.
Unlock access to complete
Funding Insights of Leica Biosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Leica Biosystems
Leica Biosystems has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Aperio Technologies, Cell IDx and Kreatech. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Immunodiagnostic reagents for immunohistochemistry are manufactured and marketed.
|
2012 | ||||
|
Digitized pathology solutions for healthcare providers
|
1999 | ||||
|
Novel FISH probes are developed for genetic aberration detection.
|
1996 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Leica Biosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Leica Biosystems Comparisons
Competitors of Leica Biosystems
Leica Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Leica Biosystems
Frequently Asked Questions about Leica Biosystems
When was Leica Biosystems founded?
Leica Biosystems was founded in 1989.
Where is Leica Biosystems located?
Leica Biosystems is headquartered in Nussloch, Germany. It is registered at Nussloch, Baden-wurttemberg, Germany.
What does Leica Biosystems do?
Leica Biosystems specializes in developing and supplying equipment for anatomic pathology workflows, including tissue processors, slide scanners, and IHC instruments. They offer consumables and software to support cancer diagnostics and laboratory operations. Based in Deer Park, Illinois, USA, they serve medical institutions, universities, and healthcare providers globally, ensuring reliable and integrated solutions for pathology challenges.
Who are the top competitors of Leica Biosystems?
Leica Biosystems's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does Leica Biosystems offer?
Leica Biosystems offers Aperio GT 450 DX, BOND IHC-ISH Instruments, and HistoCore PERMA S.
How many acquisitions has Leica Biosystems made?
Leica Biosystems has made 5 acquisitions, including Aperio Technologies, Cell IDx, and Kreatech.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.